Stay updated on MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.

Latest updates to the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; no study content or functionality were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedLocations were reorganized under a single Locations section, consolidating state entries (Colorado, Illinois, Maryland, Massachusetts, New York, Texas, Utah) and updating the page revision from v3.3.2 to v3.3.3. The HHS Vulnerability Disclosure link was removed.SummaryDifference0.9%

- Check56 days agoChange DetectedPublications section now notes that PubMed entries are auto-filled and may not all relate to the study; revision numbers updated to v3.3.2 and v3.2.0.SummaryDifference0.1%

- Check63 days agoChange DetectedThe notice about government funding lapse and NIH Clinical Center operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check77 days agoChange DetectedScreenshots indicate only minor UI/layout changes with no observable modifications to core study content (inclusion criteria, locations, enrollment, or outcome measures). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check106 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference5%

Stay in the know with updates to MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.